Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria

J Thromb Thrombolysis. 2017 Jul;44(1):63-66. doi: 10.1007/s11239-017-1502-4.

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder associated with increased risk for thrombosis and reduced life expectancy. Retinal vein occlusion (RVO) is a frequent cause of vision loss but its relationship with PNH has not been studied systematically. Patients followed up for RVO in our ophthalmology department were screened for the presence of a PNH clone in peripheral blood by means of flow cytometry. The presence of other well-documented risk factors for RVO was also analyzed. In a series of 110 patients (54 males, median age of 67) we found no evidence of PNH. Most patients (97/110) had cardiovascular risk factors and/or hyperhomocysteinemia (67/110). Inherited thrombophilias were rare (three confirmed cases). Therefore, PNH does not appear to play a role in the development of RVO. However, this finding does not necessarily apply to young patients and/or those with no conventional risk factors for RVO, due to the low number of patients in these subgroups in our population.

Keywords: Flow cytometry; Paroxysmal nocturnal hemoglobinuria; Retinal vein occlusion; Thrombophilia.

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Hemoglobinuria, Paroxysmal* / blood
  • Hemoglobinuria, Paroxysmal* / complications
  • Hemoglobinuria, Paroxysmal* / therapy
  • Humans
  • Hyperhomocysteinemia* / blood
  • Hyperhomocysteinemia* / complications
  • Hyperhomocysteinemia* / therapy
  • Male
  • Middle Aged
  • Retinal Vein Occlusion* / blood
  • Retinal Vein Occlusion* / etiology
  • Retinal Vein Occlusion* / therapy
  • Risk Factors